Skip to main content
Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Turkey | Türk
United Kingdom | English
Global | English
Sandoz | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Sandoz | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Turkey | Türk
United Kingdom | English
United States | English
    • About 
      • Novartis in country 
      • Diversity and Inclusion 
      • People and Culture 
      • Products 
      • Country Leadership Team 
      • Contact 
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Products 
      • Adverse Event Reporting 
    • Healthcare Professionals 
      • Products 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      • Healthcare professional country resource 
    • ESG 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
    • News 
      • News Archive 
      • Stories 
      • Contacts 
    • Careers 
      • Career Search 
      • Our business functions 
        • Careers in Research & Development 
        • Careers in Operations 
        • Careers in Commercial & Sales 
        • Careers in Global Functions 
      • Why Novartis 
      • Career Hub 
      • Early Careers 
        • Graduates 
        • Students 
    Inside view of the Novartis Pavillon
    Home
Header
hcp-taking-senior-patients-blood-pressure

Healthcare Professionals

Providing support and seeking collaboration

Novartis works closely with healthcare professionals around the work to support their treatment of patients and collaborate on unmet needs.
A hand with a pill tray

Products

Learn more about treatments currently offered by Novartis Innovative Medicines, Sandoz and Advanced Accelerator Applications.

A scientist with a pipette

Pipeline

COVID-19 information for healthcare professionals Novartis is working closely with healthcare professionals during the coronavirus disease pandemic

A couple holding hands

Clinical Trials

Novartis is working closely with healthcare professionals to bring clinical trials closer.

Young patients waiting outside hospital in Rwanda

Managed Access

Novartis Managed Access makes investigational or unapproved treatments available to eligible patients with serious or life-threatening diseases

Q2_HP Hero image-edited

Adverse Event Reporting

COVID-19 information for healthcare professionals Novartis is working closely with healthcare professionals during the coronavirus disease pandemic

A pair of doctors looking at something

Healthcare professional resources by country

Novartis provides information and resources through country HCP portals

Novartis

Footer Bottom
© 2025 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for a global audience